
Viking Global Investors
60 portfolio companies · 9 on the map · $2.1B raised · 8 cities
Portfolio map
8 Viking Global Investors portfolio companies on the map.
Portfolio companies

Zentalis
San Diego
Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
Biotechnology Research$896.6M
Lightmatter
Mountain View
Lightmatter develops photonic chips that enable data processing and communication using light instead of electricity.
Computer Hardware Manufacturing$822MEst. 2017
AssetWatch
Dublin
AssetWatch is a deployable, remote, end-to-end condition monitoring solution providing predictive insight to enable proactive maintenance.
Automation Machinery Manufacturing$166.1MEst. 2014
Cognism
London
Cognism is a B2B sales acceleration software company that provides a marketing and sales acceleration solution.
Software Development$126.7MEst. 2015
Pearl
New York
Pearl Health provides an integrated platform to help primary care providers focus their attention on the patients who need it.
Hospitals and Health Care$95MEst. 2020
Arctic Wolf
Eden Prairie
Arctic Wolf is a cyber security company that provides cloud-native security operations technology to reduce cyber risks.
Computer and Network SecurityEst. 2012Hiring fastHansen Medical
Mountain View
Auris Health engages in the development of robotics technology for medical applications.
Medical Equipment ManufacturingPublicEst. 2002Checkerspot
Alameda
Checkerspot is a biology driven, molecule licensing company designing fats and oils through precision fermentation.
Biotechnology ResearchSeries CEst. 2016
Canopy
California
Canopy is an AI-native platform for oncology practices that enables continuous, between-visit care, extending support beyond the clinic to improve patient outcomes and triage efficiency while generating meaningful revenue from care.
HealthTechEst. 2017
More portfolio companies
50 more Viking Global Investors investments we track beyond the map — 60 tracked in total.
ID.meMclean · Secondary Market
Oruka TherapeuticsWaltham · Post-IPO Equity
VeraDermicsNew Haven · Series C
Ginkgo BioworksBoston · Post-IPO Equity
PROCEPT BioRoboticsRedwood Shores · Series G
GeneDxStamford · Post-IPO Equity
ColorSouth San Francisco · Series E
Rockefeller Capital ManagementNew York · Private Equity
TalkdeskSan Francisco · Series D
ValsoftMontréal · Private Equity
RayzeBioSan Diego · Series D
Locus BiosciencesMorrisville · Series B
Credit KarmaSan Francisco · Series E
AlphaSenseNew York · Series F
BridgeBioPalo Alto · Series D
aTyr PharmaSan Diego · Post-IPO Equity
Ecovative DesignAlbany · Series E
IterableSan Francisco · Series E
Algen BiotechnologiesSan Francisco · Seed
HI-BioSouth San Francisco · Series B
DockSão Paulo · Private Equity
GenomaticaSan Diego · Series C
CazooLondon · Post-IPO Debt
GondolaBioPalo Alto · Venture
MyForest FoodsAlbany · Series A
AffinivaxCambridge · Series C
DruvaSanta Clara · Series H
ORIC PharmaceuticalsSouth San Francisco · Post-IPO Equity
Sionna TherapeuticsNatick · Series C
AltimmuneGaithersburg · Post-IPO Equity
Magenta MedicalKadima · Venture
Deciphera PharmaceuticalsWaltham · Series C
Yes ToSan Francisco · Private Equity
Vets First ChoicePortland · Private Equity
Joyn BioBoston · Series A
HeadLightSeattle · Series B
Adaptive BiotechnologiesSeattle · Series F
Boost BiomesSouth San Francisco · Series A
LianBioShanghai · Series A
1HealthSan Francisco · Series A
PharvarisZug · Series C
GrooveSan Francisco · Series B
Resilient BioticsRaleigh · Series A
MotifBoston · Series B
Standard BioToolsSouth San Francisco · Post-IPO Equity
Global Processing ServicesLondon · Private Equity
Eidos TherapeuticsPalo Alto · Series B
ValstoneMontréal · Private Equity
Prospect BioBrisbane · Seed
Viela BioGaithersburg · Series B
Portfolio map
8 Viking Global Investors portfolio companies on the map.